EUVIMEDEUVIMED entdecken
Crossref

Neuropsychological functioning and progression in Lafora disease

Serena Mazzone iD, Lorenzo Muccioli iD, Maria Tappatà iD, Elena Pasini iD, Giovanni Bifolchi, Nicola Pietrafusa iD, Giulia Bruschi, Berge A Minassian, Roberto Michelucci iD, Francesca Bisulli iD

Epilepsia · 2026

DOI: 10.1002/epi.70376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsia, 2026. Verfasst von Serena Mazzone und 9 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Istituto delle Scienze Neurologiche di Bologna, full member of European Reference Network EpiCARE, Bologna, Italy. Hauptthemen laut MEDLINE: Lafora Disease. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Ministero della Salute, Fondazione Epilessia LICE.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Lafora disease (LD) is a rare and severe form of progressive myoclonus epilepsy characterized by cognitive decline that ultimately leads to dementia. However, its cognitive features and adaptive functioning remain poorly understood. This study aimed to characterize the neuropsychological profile of LD and its progression.

Methods

In this monocentric cohort study, consecutive LD patients were administered a battery including cognitive measures (Leiter‐3, Children's Color Trail Test [CCTT], Wechsler Adult Intelligence Scale‐IV Vocabulary, and Visual–Motor Integration [VMI] test) and the Vineland Adaptive Behavior Scales, Second Edition (Vineland‐II). Longitudinal follow‐up data were collected after 12 months. Scores were normalized into z ‐scores for analysis.

Results

Fourteen patients (six females) were included. Mean age at onset was 12.6 ± 2.0 years (range = 10–17), and mean age at baseline assessment was 16.5 ± 2.6 years (range = 13–19). Mean Leiter‐3 intelligence quotient (IQ) was 79.8 ± 22.8 (range = 45–120); IQ was impaired in 10 of 14 patients (71%; extremely low, n = 6; borderline, n = 4). Executive dysfunction was the most prominent deficit; impairment was observed in 12 of 14 (86%) on CCTT, nine of 12 (75%) on sustained attention, eight of 12 (67%) on congruent Stroop, and 10 of 12 (83%) on incongruent Stroop. VMI was impaired in 10 of 14 (71%), and verbal abilities in four of seven (57%). Mean Vineland‐II Adaptive Behavior Composite score was 82.7 ± 33.7 (range = 20–128), in the moderately low range, mainly driven by reduced communication scores (75.9 ± 36.3, range = 20–120). Nine patients completed 12‐month follow‐up, showing significant decline in IQ, executive functions, and visuomotor integration (all p < .05), and adaptive functioning showed a downward trend. Significance LD is characterized by prominent executive dysfunction accompanied by reduced adaptive communication skills, even in the initial stages. The CCTT was sensitive in detecting early deficits and cognitive decline, supporting its use in clinical practice and research. These findings highlight the need for standardized neuropsychological testing and support its role in tracking disease progression and as an outcome measure in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lafora DiseaseHumansFemaleDisease ProgressionNeuropsychological TestsMaleAdolescentChildExecutive FunctionYoung AdultCohort StudiesIntelligenceFollow-Up Studies

Stichwörter der Autor:innen

adaptive functioningbiomarkerexecutive dysfunctionneuropsychologyprogressive myoclonus epilepsy

Autor:innen und Institutionen

  • IRCCS Istituto delle Scienze Neurologiche di Bologna, full member of European Reference Network EpiCARE, Bologna, Italy.
  • Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.
  • Neurology, Epilepsy, and Movement Disorders Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Division of Neurology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • O'Donnell Brain Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

ORCID-Profile: Serena Mazzone, Lorenzo Muccioli, Maria Tappatà, Elena Pasini, Nicola Pietrafusa, Roberto Michelucci, Francesca Bisulli

Förderung

  • Ministero della Salute
  • Fondazione Epilessia LICE

Zitieren

APA

Mazzone, S., Muccioli, L., Tappatà, M., Pasini, E., Bifolchi, G., Pietrafusa, N., Bruschi, G., Minassian, B. A., Michelucci, R., & Bisulli, F. (2026). Neuropsychological functioning and progression in Lafora disease. Epilepsia. https://doi.org/10.1002/epi.70376

Vancouver

Mazzone S, Muccioli L, Tappatà M, Pasini E, Bifolchi G, Pietrafusa N, et al. Neuropsychological functioning and progression in Lafora disease. Epilepsia. 2026. doi:10.1002/epi.70376

BibTeX
@article{Mazzone2026,
  author = {Mazzone, Serena and Muccioli, Lorenzo and Tappatà, Maria and Pasini, Elena and Bifolchi, Giovanni and Pietrafusa, Nicola and Bruschi, Giulia and Minassian, Berge A and Michelucci, Roberto and Bisulli, Francesca},
  title = {Neuropsychological functioning and progression in Lafora disease},
  journal = {Epilepsia},
  year = {2026},
  doi = {10.1002/epi.70376}
}
Kostenlos starten →